Genetic association of inflammatory marker GlycA with lung function and respiratory diseases

Abstract Association of circulating glycoprotein acetyls (GlycA), a systemic inflammation biomarker, with lung function and respiratory diseases remain to be investigated. We examined the genetic correlation, shared genetics, and potential causality of GlycA ( N = 115,078) with lung function and respiratory diseases ( N = 497,000). GlycA showed significant genetic correlation with FEV1 (r g = −0.14), FVC (r g = −0.18), asthma (r g = 0.21) and COPD (r g = 0.31). We consistently identified ten shared loci (including chr3p21.31 and chr8p23.1 ) at both SNP and gene level revealing potential shared biological mechanisms involving ubiquitination, immune response, Wnt/β-catenin signaling, cell growth and differentiation in tissues or cells including blood, epithelium, fibroblast, fetal thymus, and fetal intestine. Genetically elevated GlycA was significantly correlated with lung function and asthma susceptibility (354.13 ml decrement of FEV1, 442.28 ml decrement of FVC, and 144% increased risk of asthma per SD increment of GlycA) from MR analyses. Our findings provide insights into biological mechanisms of GlycA in relating to lung function, asthma, and COPD.